They are one and the same. You want to move it without affecting the temperature.
When we work these storage temperatures out what we do is set non-arbitrary values we aren't willing to go beyond.
For example, we know that the degradation pathway of A is to become B. Therefore we set a maximum amount of B before we know it impacts the effective level of A.
Then we run that test. We place it under various conditions to see how quickly it becomes B. It's a natural progression to go from 24 to 72 hours to 1 week. When the clinical trials are designed they have to account for the time it'll likely be out of ultra cold storage - this is a risk assessment borne of a worst-case-scenario.
In this case I'd bet my life they know 5 days is adequate for use of the vaccine (2-8c) and that -70c doesn't give rise to degradation. Why go further? There's no reason to. It may not have even passed clinical trials p1. You don't invest time and money into whatiffery.